The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Neurotrophic–Inflammatory Imbalance and Cognitive Decline After Adjuvant Chemotherapy in Colon Cancer: A Prospective Cohort Study
Abstract
Background: Cancer‐related cognitive impairment (CRCI) is a prevalent yet underrecognized complication among colon cancer survivors that adversely affects quality of life and psychological well‐being. Emerging evidence suggests that neurotrophic dysregulation and systemic inflammation may contribute to chemotherapy‐related neurotoxicity; however, longitudinal biomarker‐based data remain limited. Methods: In this prospective cohort study, 127 patients with resected colon cancer were evaluated at baseline and at the 6‐month follow‐up. Of these, 83 received adjuvant chemotherapy and 44 underwent postoperative surveillance alone. Cognitive performance (MoCA), depressive symptoms (HADS‐D), and peripheral neuropathy (CIPN20) were assessed alongside serum brain‐derived neurotrophic factor (BDNF) levels and systemic inflammatory markers, including neutrophil‐to‐lymphocyte ratio (NLR) and C‐reactive protein‐to‐albumin ratio (CAR). Linear mixed model and logistic regression analyses were performed to identify factors associated with cognitive decline. Results: Adjuvant chemotherapy was associated with significant reductions in MoCA scores and serum BDNF levels (both p < 0.001), particularly among patients receiving the oxaliplatin‐based XELOX regimen. Greater longitudinal reductions in BDNF (ΔBDNF) were independently associated with higher odds of CRCI (OR = 0.749 per 10 ng/mL increase in ΔBDNF, 95% CI: 0.658–0.854, p < 0.001). The model including ΔBDNF showed higher apparent discrimination than the corresponding model without ΔBDNF (AUC = 0.929 vs. 0.812). Conclusion: Longitudinal reductions in serum BDNF were independently associated with CRCI among patients receiving adjuvant chemotherapy. These findings support a potential role for neurotrophic dysregulation in chemotherapy‐related cognitive decline and highlight the need for further validation studies evaluating BDNF as a candidate biomarker for CRCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening and Surveillance of Colorectal Cancer: A Review of the Literature
Maida, M., Dahiya, D. S., Shah, Y. R., Tiwari, A., Gopakumar, H., Vohra, I., Khan, A., Jaber, F., Ramai, D., & Facciorusso, A. (2024) · Cancers · doi:10.3390/cancers16152746 · Cited by 43
Research works printed but not linked: 25
- 10.1093/jnci/djae209 · DOI
- 10.1038/s41582‐021‐00617‐2 · DOI
- 10.3390/medsci13030191 · DOI
- 10.1200/JCO.2015.63.0905 · DOI · Paper page
- 10.1016/j.clcc.2018.09.002 · DOI
- 10.1007/s10549‐020‐05898‐7 · DOI
- 10.1111/ene.14522 · DOI
- 10.1200/JCO.2016.68.5826 · DOI
- 10.3390/ijms262010074 · DOI · Paper page
- 10.3390/cancers13164198 · DOI
- 10.1093/arclin/acae013 · DOI
- 10.1177/26331055231220906 · DOI
- 10.1038/s41598‐023‐43581‐1 · DOI · Paper page
- 10.1016/j.cyto.2021.155556 · DOI
- 10.1016/j.tranon.2021.101297 · DOI
- 10.1016/j.neubiorev.2010.09.006 · DOI
- 10.1016/j.neuropharm.2024.109981 · DOI
- 10.1093/annonc/mdz410 · DOI · Paper page
- 10.1007/s12282‐025‐01757‐9 · DOI
- 10.1007/s40211‐020‐00345‐x · DOI
- 10.3332/ecancer.2025.1958 · DOI
- 10.1002/pon.6073 · DOI · Paper page
- 10.1002/pon.4156 · DOI
- 10.1007/s13311‐022‐01339‐z · DOI
- 10.3390/ijms24032411 · DOI
Metadata
- Authors
- Güç, Z. G., Demir, L., Döngelli, H., Bilen, İ., Uge, M., Kalender, M. E., Alacacıoğlu, A., & Tarhan, M. O.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2026-08
- Volume
- 35
- Issue
- 8
- ISSN
- 1057-9249
- 1099-1611
- Cited by
- 0
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurotrophic–Inflammatory Imbalance and Cognitive Decline After Adjuvant Chemotherapy in Colon Cancer: A Prospective Cohort Study. https://app.cochat.ai/papers/10.1002/pon.70590
- The paper
- Güç, Z. G., Demir, L., Döngelli, H., Bilen, İ., Uge, M., Kalender, M. E., Alacacıoğlu, A., & Tarhan, M. O. (2026). Neurotrophic–Inflammatory Imbalance and Cognitive Decline After Adjuvant Chemotherapy in Colon Cancer: A Prospective Cohort Study. Psycho-Oncology. https://doi.org/10.1002/pon.70590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
